Laluck B J, Cattran D C
Department of Medicine, University of Toronto, Toronto, Canada.
Am J Kidney Dis. 1999 Jun;33(6):1026-32. doi: 10.1016/S0272-6386(99)70138-1.
This review of the long-term outcome after a complete remission of proteinuria includes 82 adult patients with biopsy-proven idiopathic membranous glomerulonephritis (IMGN), who represented 25% of the total cases (82 of 323 cases) of IMGN in our registry. Complete remission was defined as at least two consecutive follow-up evaluations showing proteinuria of 0.3 g/d or less of protein. Before remission, 70% of the patients had nephrotic-range proteinuria (61% at presentation, 9% during follow-up), and 30% were always subnephrotic (protein level < 3.5 g/d). Mean total observation time was 101 +/- 56 months, with a postremission period of 69 +/- 60 months. Seventy-one percent of the patients remained in remission and 29% relapsed. In the relapse group, 46% relapsed to nephrotic-range proteinuria and 54% relapsed to subnephrotic levels. The plasma creatinine level remained stable in 86% of the patients (71 of 82 patients) but became or remained elevated despite a period of complete remission in the remaining 14% (8 of 82 patients). No patient went on to end-stage renal disease. Seventy-seven percent of the patients had no specific treatment within 6 months of remission, whereas 23% had steroid therapy alone or in combination with an immunosuppressive agent. In a multivariate analysis, the factors that favored both remission and its durability were persistent lower levels of proteinuria and female sex. Complete remission indicates an excellent long-term prognosis in patients with IMGN, but relapses are common and, in a small percentage, chronic renal insufficiency occurs. Thus, our data suggest that even this group of patients should be monitored on a regular basis.
本项关于蛋白尿完全缓解后的长期预后的综述纳入了82例经活检证实为特发性膜性肾小球肾炎(IMGN)的成年患者,这些患者占我们登记的IMGN总病例数(323例中的82例)的25%。完全缓解定义为至少两次连续的随访评估显示蛋白尿≤0.3g/d。缓解前,70%的患者有肾病范围蛋白尿(初诊时61%,随访期间9%),30%的患者蛋白尿始终低于肾病范围(蛋白水平<3.5g/d)。平均总观察时间为101±56个月,缓解期为69±60个月。71%的患者保持缓解,29%复发。在复发组中,46%复发至肾病范围蛋白尿,54%复发至低于肾病范围水平。86%的患者(82例中的71例)血浆肌酐水平保持稳定,但其余14%(82例中的8例)患者尽管有一段时间完全缓解,肌酐水平仍升高或持续升高。无患者进展至终末期肾病。77%的患者在缓解后6个月内未接受特殊治疗,而23%的患者仅接受了类固醇治疗或联合免疫抑制剂治疗。多因素分析显示,有利于缓解及其持续性的因素是蛋白尿持续处于较低水平和女性性别。完全缓解表明IMGN患者长期预后良好,但复发常见,且有小部分患者会发生慢性肾功能不全。因此,我们的数据表明,即使是这组患者也应定期监测。